Agilent Technologies, Inc. (NYSE:A) Position Raised by Vinva Investment Management Ltd

Vinva Investment Management Ltd boosted its position in Agilent Technologies, Inc. (NYSE:A) by 34.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,453 shares of the medical research company’s stock after purchasing an additional 3,440 shares during the period. Vinva Investment Management Ltd’s holdings in Agilent Technologies were worth $1,992,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. grew its stake in shares of Agilent Technologies by 47.9% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock worth $768,000 after purchasing an additional 1,711 shares during the last quarter. Atria Investments Inc grew its position in Agilent Technologies by 26.6% in the first quarter. Atria Investments Inc now owns 11,841 shares of the medical research company’s stock worth $1,723,000 after buying an additional 2,491 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after buying an additional 29,590 shares in the last quarter. Cetera Advisors LLC lifted its position in shares of Agilent Technologies by 45.7% during the 1st quarter. Cetera Advisors LLC now owns 13,620 shares of the medical research company’s stock valued at $1,982,000 after acquiring an additional 4,274 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Agilent Technologies by 36.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 731 shares of the medical research company’s stock worth $100,000 after acquiring an additional 195 shares in the last quarter.

Agilent Technologies Price Performance

A opened at $137.98 on Friday. The stock has a fifty day moving average price of $137.60 and a 200 day moving average price of $137.37. The company has a current ratio of 2.09, a quick ratio of 1.37 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The stock has a market cap of $39.65 billion, a price-to-earnings ratio of 31.22, a PEG ratio of 4.38 and a beta of 1.07.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.72%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s payout ratio is currently 21.27%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Wells Fargo & Company started coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday. StockNews.com cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday. Barclays dropped their target price on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday. Finally, Sanford C. Bernstein reduced their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $143.40.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.